VERELAN PM

Product NDC: 62175-572
11-digit product format: 621750572
Labeler code: 62175
Product ID: 62175-572_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: verapamil hydrochloride
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Lannett Company, Inc.
Application: NDA020943
Marketing category: NDA
Marketing start: 1998-11-25
Marketing end: 0000-00-00
Substance: VERAPAMIL HYDROCHLORIDE
Active strength: 300 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2024-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62175-572		D	Discontinued by firm		2026-10-20
excluded package	package	62175-572	62175-572-37	D	Discontinued by firm		2026-10-20

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N020943-001	VERELAN PM	VERAPAMIL HYDROCHLORIDE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25
N020943-002	VERELAN PM	VERAPAMIL HYDROCHLORIDE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25
N020943-003	VERELAN PM	VERAPAMIL HYDROCHLORIDE	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020943-002	VERELAN PM	200MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020943-003	VERELAN PM	300MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1998-11-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020943-001	VERELAN PM	100MG	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1998-11-25	`79d66fd596c7…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020943-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020943-002	AB	1	`74a2ff9319b5…`
2019-09-15 20:21 UTC	2019-09	N020943-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020943-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020943-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020943-002	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4	Product name	2	20230103
33ad674d-d105-6aa5-02fa-95ae4329b8cd	Product name	2	20180809
3279bd6d-5b02-e60b-3857-c853a2deb2dd	Product name	2	20170713
8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a	Product name	1	20140508
940a1faa-2df8-cc65-be37-1b97984b4ea3	Product name	1	20140508
d3b67bc2-0e96-e3ec-06a9-90afcc07bf13	Product name	1	20140508
e2fcd66c-a043-3187-790d-b0342deb1149	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62175-572-37	VERELAN PM	100 in 1 BOTTLE, PLASTIC	CAPSULE, EXTENDED RELEASE	100		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62175-572-37	EA - Each	62175-572	c44376a5-33a2-4bd3-a81b-1ad6f3436786	1	2014-01-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
verapamil hydrochloride	ACTIVE INGREDIENT	V3888OEY5R	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
verapamil	ACTIVE MOIETY	CJ0O37KU29	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
FUMARIC ACID	INACTIVE INGREDIENT	88XHZ13131	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
SHELLAC	INACTIVE INGREDIENT	46N107B71O	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
SUCROSE	INACTIVE INGREDIENT	C151H8M554	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62175-572	VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]	11	Legacy NDC, 1 package rows	20230105_fd1b433f-1895-4af0-9d1f-3901c6d34c20.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Chartwell RX, LLC	18f6d349-8c5c-4443-ac65-16bf6619ecdc	2025-03-25	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020943 application number: NDA020943
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Wilshire Pharmaceuticals, Inc.	5f665d08-e1e4-422a-88c2-d8834abf9e1a	2024-11-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020943 application number: NDA020943

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V3888OEY5R	VERAPAMIL HYDROCHLORIDE	152-11-4	VERAPAMIL HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
62175-572-37	62175057237	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62175-572-37)	1998-11-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
VERELAN PM	Lannett Company, Inc. \| Societal CDMO Gainesville, LLC	2022-07-01	HUMAN PRESCRIPTION DRUG LABEL	11
Recro Gainesville LLC blanket no changes certification of product listing	Recro Gainesville LLC	2017-10-04	BLANKET NO CHANGES CERTIFICATION OF PRODUCT LISTING	1